Combination Therapy with Interferon-Alpha2a and Ruxolitinib in Newly Diagnosed Patients with Polycythemia Vera. A Danish Safety and Efficacy Study.
Latest Information Update: 06 Jul 2019
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ruxolitinib (Primary)
- Indications Polycythaemia vera
- Focus Adverse reactions
- 28 Mar 2019 New trial record